These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 23034269

  • 1. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
    Angelini A, Di Pietro R, Centurione L, Castellani ML, Conti P, Porreca E, Cuccurullo F.
    J Biol Regul Homeost Agents; 2012; 26(3):495-504. PubMed ID: 23034269
    [Abstract] [Full Text] [Related]

  • 2. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
    Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F.
    J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
    [Abstract] [Full Text] [Related]

  • 3. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines.
    Angelini A, Centurione L, Sancilio S, Castellani ML, Conti P, Di Ilio C, Porreca E, Cuccurullo F, Di Pietro R.
    J Biol Regul Homeost Agents; 2011; 25(2):203-11. PubMed ID: 21880209
    [Abstract] [Full Text] [Related]

  • 4. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
    Angelini A, Conti P, Ciofani G, Cuccurullo F, Di Ilio C.
    J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
    [Abstract] [Full Text] [Related]

  • 5. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
    Angelini A, Ciofani G, Conti P.
    J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
    [Abstract] [Full Text] [Related]

  • 6. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
    Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A.
    Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.
    Hung TH, Chen CM, Tseng CP, Shen CJ, Wang HL, Choo KB, Chong KY.
    Int J Biochem Cell Biol; 2014 Aug 21; 53():55-65. PubMed ID: 24814288
    [Abstract] [Full Text] [Related]

  • 13. Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5.
    Choi JS, Kang NS, Min YK, Kim SH.
    Phytother Res; 2010 Jul 21; 24(7):1042-6. PubMed ID: 19960428
    [Abstract] [Full Text] [Related]

  • 14. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.
    Chang CC, Huang LH, Chiang W, Hsia SM.
    Phytomedicine; 2018 Aug 01; 47():69-80. PubMed ID: 30166110
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
    Traunecker HC, Stevens MC, Kerr DJ, Ferry DR.
    Br J Cancer; 1999 Nov 01; 81(6):942-51. PubMed ID: 10576649
    [Abstract] [Full Text] [Related]

  • 17. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.
    Park S, James CD.
    Cancer Res; 2003 Feb 01; 63(3):723-7. PubMed ID: 12566319
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q.
    Yao Xue Xue Bao; 2005 May 01; 40(5):475-80. PubMed ID: 16220797
    [Abstract] [Full Text] [Related]

  • 20. Monitoring incorporation, transformation and subcellular distribution of N-l-leucyl-doxorubicin in uterine sarcoma cells using capillary electrophoretic techniques.
    Wang Y, Arriaga EA.
    Cancer Lett; 2008 Apr 08; 262(1):123-32. PubMed ID: 18194838
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.